← Leaderboards
Marianne Hamilton Lopez
Duke University
$9,528,155
Attributed
$9,528,155
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2020–25$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$9,528,155 · 3
By mechanism
U19$5,583,873 · 1
U01$3,944,282 · 2
Top collaborators
No co-investigators on record.
Grant awards (15)
Cooperative Agreement to Support Regulatory Research Related to the 2022 Prescription Drug User Fee Act and Biosimilar User Fee Act (U19)$1,007,784
U19 · FY2025 · FD · contact PI
Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, and Policy Development of Medical Products for Ongoing Public Health Activities, U01 Clinical Trial Not Allowed$699,999
U01 · FY2025 · FD · contact PI
Cooperative Agreement to Support Regulatory Research Related to the 2022 Prescription Drug User Fee Act and Biosimilar User Fee Act (U19)$1,006,000
U19 · FY2024 · FD · contact PI
Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, and Policy Development of Medical Products for Ongoing Public Health Activities, U01 Clinical Trial Not Allowed$700,000
U01 · FY2024 · FD · contact PI
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities$300,000
U01 · FY2024 · FD · contact PI
Cooperative Agreement to Support Regulatory Research Related to the 2022 Prescription Drug User Fee Act and Biosimilar User Fee Act (U19)$950,781
U19 · FY2023 · FD · contact PI
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities$400,000
U01 · FY2023 · FD · contact PI
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities$218,066
U01 · FY2023 · FD · contact PI
Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U19)$897,181
U19 · FY2022 · FD · contact PI
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities$477,000
U01 · FY2022 · FD · contact PI
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities$249,217
U01 · FY2022 · FD · contact PI
Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U19)$873,663
U19 · FY2021 · FD · contact PI
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities$450,000
U01 · FY2021 · FD · contact PI
Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U19)$848,464
U19 · FY2020 · FD · contact PI
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities$450,000
U01 · FY2020 · FD · contact PI